| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.20B | +11.9% |
| Gross profit | ¥0.07B | — |
| Operating income | ¥0.04B | — |
| Net income | ¥0.03B | +2.1% |
| Gross margin | 34.8% | Net margin 15.9% |
| Revenue Q/Q | +29.6% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.13B | 65.2% |
| R&D | ¥0.02B | 8.2% |
| SG&A | ¥0.01B | 6.4% |
| Tax & other | ¥0.00B | 2.1% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
广康生化 ・ 电声股份 ・ 斯迪克 ・ 天迈科技 ・ 久量股份 ・ 华辰装备 ・ 中科海讯 ・ 铂科新材 ・ 易天股份 ・ 泰林生物 ・ 中富电路 ・ 玉禾田
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies